PT  - JOURNAL ARTICLE
AU  - Hunter, Lisa L.
AU  - Blankenship, Chelsea M.
AU  - Shinn-Cunningham, Barbara
AU  - Hood, Linda
AU  - Zadeh, Lina Motlagh
AU  - Moore, David R.
TI  - Brainstem Auditory Physiology in Children with Listening Difficulties
AID  - 10.1101/2022.07.12.22277544
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.07.12.22277544
4099  - http://medrxiv.org/content/early/2022/07/12/2022.07.12.22277544.short
4100  - http://medrxiv.org/content/early/2022/07/12/2022.07.12.22277544.full
AB  - Children who have listening difficulties (LiD) despite having normal audiometry are often diagnosed as having an auditory processing disorder (APD). A lack of evidence regarding involvement of specific auditory mechanisms has limited development of effective treatments for these children. Here, we examined electrophysiologic evidence for brainstem pathway mechanisms in children with and without defined LiD. We undertook a prospective controlled study of 132 children aged 6-14 years with normal pure tone audiometry, grouped into LiD (n=63) or Typically Developing (TD; n=69) based on scores on the Evaluation of Children’s Listening and Processing Skills (ECLiPS), a validated caregiver report. The groups were matched on age at test, sex, race, and ethnicity. Neither group had diagnoses of major neurologic disorder, intellectual disability, or brain injuries. Both groups received a test battery designed to measure receptive speech perception against distractor speech, Listening in Spatialized Noise - Sentences (LiSN-S), along with multiple neurophysiologic measures that tap afferent and efferent auditory subcortical pathways. Group analysis showed that participants with LiD performed significantly more poorly on all subtests of the LiSN-S. The LiD group had significantly steeper wideband middle ear muscle reflex (MEMR) growth functions and shorter Wave III, Wave V, and I-V interpeak latencies in their auditory brainstem responses (ABR). Across individual participants, shorter latency ABR Wave V correlated significantly with poorer parent report of LiD (ECLiPS composite). Steeper MEMR growth functions also correlated with poorer ECLiPS scores and reduced LiSN-S talker advantage. The LiD and TD groups had equivalent summating potentials, compound action potentials, envelope-following responses (EFR), and binaurally activated medial olivocochlear reflexes (MOCR). In conclusion, there was no evidence for auditory synaptopathy or lower brainstem dysfunction for LiD. Evidence for higher brainstem differences between groups showed that the LiD group had increased efferent control or central gain, with shorter ABR Wave III and V latencies and steeper MEMR growth curves. These differences were related to poorer parent report and speech perception ability.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the National Institute of Deafness and other Communication Disorders of the National Institutes of Health under Award Number R01 DC014078 and the National Center for Advancing Translational Sciences of the National Institutes of Health, under Award Number UL1TR001425. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Cincinnati Children's Hospital Medical Center gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.